The Cooper Companies, Inc. logo
The Cooper Companies, Inc. (COO)
Compare

The Cooper Companies, Inc. (COO) Average EV/EBIT Ratio

EV/EBIT Ratio

The current ev/ebit ratio for The Cooper Companies, Inc. (COO) is 31.25x as of Sunday, June 14, 2026, shown against its trailing averages.

Average EV/EBIT Ratio Chart

COO EV/EBIT Ratio Averages

EV/EBIT RATIO CURRENT

31.25x

EV/EBIT RATIO TTM

23.67x

EV/EBIT RATIO 3Y

31.83x

EV/EBIT RATIO 5Y

35.66x

EV/EBIT RATIO 10Y

37.23x

EV/EBIT RATIO 15Y

32.98x

EV/EBIT RATIO 20Y

30.38x

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA
16,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White